Born and raised in Indiana, USA, Dr Josh Blazek holds a Bachelors of Arts Degree in Biology from Wabash College and a PhD in Genetics and Developmental Biology from Purdue University.

His thesis work focused on the molecular origin of osteoporosis in a Down’s syndrome mouse model, and a targeted treatment therapy to alleviate the phenotype.

He was Senior Research and Development Scientist at Genesis Genetics before becoming Director of Engineering at CooperGenomics, following their acquirement by the Cooper Companies.